Higher PAI-1 levels were measured in EPP as compared to subjects from cohort A (20 vs. 4.0 U/mL; P < 0.001; Table 3), and no difference in MIF levels was observed between EPP and cohort A. The gene discussed is MIF; the disease is autosomal erythropoietic protoporphyria.